Your browser doesn't support javascript.
loading
Inhibitory effects on L- and N-type calcium channels by a novel CaVß1 variant identified in a patient with autism spectrum disorder.
Despang, Patrick; Salamon, Sarah; Breitenkamp, Alexandra; Kuzmenkina, Elza; Matthes, Jan.
Affiliation
  • Despang P; Center of Pharmacology, Institute II, University of Cologne, Gleueler Strasse 24, 50931, Köln, Cologne, Germany.
  • Salamon S; Center of Pharmacology, Institute II, University of Cologne, Gleueler Strasse 24, 50931, Köln, Cologne, Germany.
  • Breitenkamp A; Center of Pharmacology, Institute II, University of Cologne, Gleueler Strasse 24, 50931, Köln, Cologne, Germany.
  • Kuzmenkina E; Center of Pharmacology, Institute II, University of Cologne, Gleueler Strasse 24, 50931, Köln, Cologne, Germany.
  • Matthes J; Center of Pharmacology, Institute II, University of Cologne, Gleueler Strasse 24, 50931, Köln, Cologne, Germany. jan.matthes@uni-koeln.de.
Naunyn Schmiedebergs Arch Pharmacol ; 395(4): 459-470, 2022 04.
Article in En | MEDLINE | ID: mdl-35122502

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Channels, L-Type / Calcium Channels, N-Type / Autism Spectrum Disorder Type of study: Prognostic_studies Limits: Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2022 Document type: Article Affiliation country:

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Calcium Channels, L-Type / Calcium Channels, N-Type / Autism Spectrum Disorder Type of study: Prognostic_studies Limits: Humans Language: En Journal: Naunyn Schmiedebergs Arch Pharmacol Year: 2022 Document type: Article Affiliation country: